Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Johnson & Johnson at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Johnson & Johnson brings 2 presentations to SITC 2026 in Phoenix. Its program centres on immune-cell engagers and bispecific antibodies, set against cell therapy. It covers where approved and near-approval engagers stand today and weighs them directly against cell therapies, alongside a hand in launching new biotech companies.

OrganizationSITC 2026 Attendance
Johnson & Johnson
New Brunswick, NJ
jnj.com
Large pharma
Pharmaceutical business of Johnson & Johnson, formerly Janssen, developing oncology medicines including bispecific antibodies and cell therapy.
Talk
Thu Nov 5
11:30am–11:50am
Talk
Thu Nov 5
10:05am–10:20am
Workshop
Thu Nov 5
5:00pm–9:00pm
Launching Biotech Startups: Funding, Pitching, Partnerships
  1. 5:00pm–5:45pmWelcome Reception
  2. 5:55pm–6:55pmHigh-Impact Talks from Pharma Leaders
  3. 6:55pm–7:15pmPanel
  4. 7:00pm–7:50pmFinancing and Partnership Panel
  5. 8:00pm–9:00pmClosing Networking Reception

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Johnson & Johnson

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction